What is it about?
This is a case of drug-induced PAH secondary to a drug, dasatinib, that resolved completely following administration of combination PAH targeted therapy.
Featured Image
Why is it important?
Drug-induced PAH resolves following cessation of the drug, but often hemodynamic abnormalities persist. This case highlights a potential role of targeted PAH therapy in resolving cases of drug-induced pulmonary vascular disease.
Read the Original
This page is a summary of: Combination targeted pulmonary hypertension therapy in the resolution of Dasatinib-associated pulmonary arterial hypertension, Pulmonary Circulation, July 2017, SAGE Publications,
DOI: 10.1177/2045893217716659.
You can read the full text:
Contributors
The following have contributed to this page